+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology



Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology



Bone 81: 122-130



Denosumab reduced the incidence of new fractures in postmenopausal women with osteoporosis by 68% at the spine and 40% at the hip over 36 months compared with placebo in the FREEDOM study. This efficacy was supported by improvements from baseline in vertebral (18.2%) strength in axial compression and femoral (8.6%) strength in sideways fall configuration at 36 months, estimated in Newtons by an established voxel-based finite element (FE) methodology. Since FE analyses rely on the choice of meshes, material properties, and boundary conditions, the aim of this study was to independently confirm and compare the effects of denosumab on vertebral and femoral strength during the FREEDOM trial using an alternative smooth FE methodology. Unlike the previous FE study, effects on femoral strength in physiological stance configuration were also examined. QCT data for the proximal femur and two lumbar vertebrae were analyzed by smooth FE methodology at baseline, 12, 24, and 36 months for 51 treated (denosumab) and 47 control (placebo) subjects. QCT images were segmented and converted into smooth FE models to compute bone strength. L1 and L2 vertebral bodies were virtually loaded in axial compression and the proximal femora in both fall and stance configurations. Denosumab increased vertebral body strength by 10.8%, 14.0%, and 17.4% from baseline at 12, 24, and 36 months, respectively (p<0.0001). Denosumab also increased femoral strength in the fall configuration by 4.3%, 5.1%, and 7.2% from baseline at 12, 24, and 36 months, respectively (p<0.0001). Similar improvements were observed in the stance configuration with increases of 4.2%, 5.2%, and 5.2% from baseline (p≤0.0007). Differences between the increasing strengths with denosumab and the decreasing strengths with placebo were significant starting at 12 months (vertebral and femoral fall) or 24 months (femoral stance). Using an alternative smooth FE methodology, we confirmed the significant improvements in vertebral body and proximal femur strength previously observed with denosumab. Estimated increases in strength with denosumab and decreases with placebo were highly consistent between both FE techniques.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057470325

Download citation: RISBibTeXText

PMID: 26141837

DOI: 10.1016/j.bone.2015.06.025


Related references

Prediction of proximal femur strength by a quantitative computed tomography-based finite element method--Creation of predicted strength data of the proximal femur according to age range in a normal population. Modern Rheumatology 26(1): 151-155, 2016

Improvements in vertebral body strength under teriparatide treatment assessed in vivo by finite element analysis: results from the EUROFORS study. Journal of Bone and Mineral Research 24(10): 1672-1680, 2009

Prediction of strength and strain of the proximal femur by a CT-based finite element method. Journal of Biomechanics 40(8): 1745-1753, 2007

Left-right differences in the proximal femur's strength of post-menopausal women: a multicentric finite element study. Osteoporosis International 27(4): 1519-1528, 2016

Proximal femur bone strength estimated by a computationally fast finite element analysis in a sideways fall configuration. Journal of Biomechanics 46(7): 1231-1236, 2013

Analysis of strength and failure pattern of human proximal femur using quantitative computed tomography (QCT)-based finite element method. Bone 64: 108-114, 2014

Quantitative computed tomography-based finite element models of the human lumbar vertebral body: effect of element size on stiffness, damage, and fracture strength predictions. Journal of Biomechanical Engineering 125(4): 434-438, 2003

Measurement reproducibility of magnetic resonance imaging-based finite element analysis of proximal femur microarchitecture for in vivo assessment of bone strength. Magma 28(4): 407-412, 2015

Finite element analysis applied to 3-T MR imaging of proximal femur microarchitecture: lower bone strength in patients with fragility fractures compared with control subjects. Radiology 272(2): 464-474, 2014

Effect of the pedicle and posterior arch on vertebral body strength predictions in finite element modeling. Spine 23(8): 899-907, 1998

Multiple loading conditions analysis can improve the association between finite element bone strength estimates and proximal femur fractures: a preliminary study in elderly women. Bone 67: 71-80, 2014

Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone (New York) 33(4): 744-750, 2003

Comparison of explicit finite element and mechanical simulation of the proximal femur during dynamic drop-tower testing. Journal of Biomechanics 48(2): 224-232, 2015

Comparison of 3D finite element analysis derived stiffness and BMD to determine the failure load of the excised proximal femur. Medical Engineering & Physics 31(6): 668-672, 2009

Noninvasive prediction of vertebral body compressive strength using nonlinear finite element method and an image based technique. Physica Medica 26(2): 88-97, 2010